MANNKIND CORP Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
MANNKIND CORP (MNKD) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $114.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-25.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2020-02-25
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2018-12-31 was $104.00K.
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2017-12-31 was -$24.00K.
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2017-09-30 was -$92.00K.
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2015-12-31 was -$140.56M.
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2018 was $114.00K.
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2017 was -$203.00K.
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2016 was -$1.26M.
- MANNKIND CORP gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2015 was -$140.58M.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 1 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month as first filed | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month as first filed | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $114.00K 10-K · filed 2020-02-25 | |||||
| 2018-09-30 | $10.00K 10-Q · filed 2019-11-08 | ||||||
| 2017-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$116.00K derived: sum of 2 quarters · filed 2019-02-26 | -$203.00K 10-K · filed 2019-02-26 | ||||
| 2017-09-30 | -$92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$179.00K 10-Q · filed 2018-11-01 | $24.00K 10-Q · filed 2017-11-07 | ||||
| 2017-06-30 | -$87.00K 10-Q · filed 2018-08-02 | $24.00K 10-Q · filed 2017-08-07 | |||||
| 2016-12-31 | -$1.26M 10-K · filed 2019-02-26 | ||||||
| 2015-12-31 | -$140.56M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$140.57M derived: sum of 2 quarters · filed 2018-02-27 | -$140.58M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | -$27.00K 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | -$12.00K 10-Q/A · filed 2016-08-10 | ||||||
| 2014-12-31 | -$97.00K 10-K · filed 2017-03-16 | ||||||
| 2009-12-31 | -$12.80M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |